Tiziana Life Sciences Ltd
TLSA | NASDAQ
$0.62
-$0.02 (-2.82%)
At close: Nov 5, 2026, 4:00 PM ET
$0.62
$0.00 (+0.53%)
After-hours:
Nov 5, 2026, 4:22 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Mar 31, 2022 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -25.19M | -18.43M | -11.39M | -9.44M | -10.86M | -13.98M | -15.68M | -12.59M | -5.97M | -10.75M | -17.03M |
Depreciation & Amortization | 304K | 234K | 149K | 124K | 104K | 96K | 101K | 51K | 7.5K | 80.27K | 123.47K |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.17M | 321.69K | 2.99M |
Other Working Capital | 6.66M | 3.75M | -1.67M | 648.67K | 4.28M | -103.17K | -1.95M | -835.86K | -1.6M | -1.46M | -493.77K |
Other Non-Cash Items | 4.42M | 2.29M | 6.36M | 8.55M | 3.48M | 2.73M | 3.86M | -2.59M | -5.53M | -6.94M | -7.43M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 7.08M | 3.06M | -3.48M | -456.39K | 4.18M | -1.24M | -3.56M | -964.33K | -1.73M | -347.09K | 2.53M |
Operating Cash Flow | -13.38M | -12.85M | -8.36M | -1.22M | -3.09M | -12.4M | -15.27M | -16.09M | -14.39M | -17.63M | -18.82M |
Capital Expenditures | -75K | -21K | -9.99K | -15.06K | -11.06K | n/a | n/a | n/a | -501 | -21.34K | -20.93K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | -791.35K | -791.35K | -2.18M | -2.18M | n/a | n/a | n/a |
Sales Maturities Of Investments | -2.89M | n/a | 2.89M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 3.06M | 3.06M | -41.55K | -41.55K | 791.35 | -199.73K | 1.56M | -1.11M | -4.2M | -1.34M | n/a |
Investing Cash Flow | 103K | 3.04M | 2.83M | -56.61K | -801.62K | -991.08K | -618.71K | -3.29M | -4.2M | -1.36M | -147.58K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8.81K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -402.87K | -806.24K | -403.37K | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -278K | -196K | -105.54K | -112.05K | -119.4K | -94.1K | -74.04K | -44.84K | 92.43 | -274.88K | -557.01K |
Financial Cash Flow | 9.16M | 10.01M | 11.02M | 3.6M | 6.42K | 31.73K | -74.04K | -447.71K | -806.24K | -678.34K | 59.5M |
Net Cash Flow | -4.07M | 286K | 5.6M | 2.03M | -4.33M | -13.38M | -15.96M | -28.93M | -74.09M | -64.61M | 44.43M |
Free Cash Flow | -13.46M | -12.87M | -8.37M | -1.24M | -3.1M | -12.4M | -15.27M | -16.09M | -14.39M | -17.65M | -18.84M |
Adj. Free Cash Flow | -13.46M | -12.87M | -8.37M | -1.24M | -3.1M | -12.4M | -15.27M | -16.09M | -13.22M | -17.98M | -21.82M |
Maintenance CapEx | -84.99K | -36.05K | -21.05K | -15.06K | -11.06K | n/a | -501 | -21.34K | -21.43K | -23.95K | -26.39K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -21.83M | -14.11M | -11.47M | -13.64M | -18.37M | -28.49M | -29.66M | -33.74M | -33.23M | -29.8M | -26.69M |
Add to Watchlist
Select watchlists to add or remove TLSA